DOI:
10.1055/s-00000142
Frauenheilkunde up2date
LinksClose Window
References
Slamon DJ, Leyland-Jones B, Shak S. et al.
Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.
N Engl J Med 2001;
344: 783-792
We do not assume any responsibility for the contents of the web pages of other providers.